IL1B and lip and oral cavity carcinoma: IL-1β is overexpressed in the saliva of oral cancer patients compared to oral leukoplakia and control patients [152, 153] and IL-1β salivary levels have been shown to discriminate between OSCC subjects and controls [154–156], but not between oral potentially malignant disorder (OPMD) patients and healthy subjects [155].